Bio-Rad Laboratories, Inc.Class A BIO
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-12T03:21:36.036Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.002685134Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T03:21:35.616573+00:00
Bio-Rad Laboratories, Inc.Class A options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 415.85 | 53.0% | 8.6% | 363.67 | 47.8% | 6.7% |
| 25Δ | 410.98 | 54.7% | 7.7% | 368.12 | 48.1% | 5.8% |
| 30Δ | 403.42 | 47.8% | 5.9% | 372.94 | 44.2% | 4.7% |
| 35Δ | 397.89 | 44.0% | 4.7% | 378.03 | 37.3% | 3.5% |
| 40Δ | 394.29 | 43.9% | 4.1% | 381.56 | 34.1% | 2.7% |
| 45Δ | 390.68 | 43.7% | 3.5% | 384.11 | 33.3% | 2.3% |
| 50Δ | 387.44 | 42.6% | 3.0% | 386.65 | 32.4% | 2.0% |
| 55Δ | 384.28 | 41.3% | 2.5% | 389.20 | 31.6% | 1.6% |
| 60Δ | 381.11 | 40.0% | 2.0% | 391.98 | 31.7% | 1.3% |
| 65Δ | 377.55 | 40.4% | 1.6% | 394.86 | 32.2% | 1.1% |
| 70Δ | 373.76 | 41.8% | 1.4% | 397.75 | 32.7% | 0.9% |
| 75Δ | 369.97 | 43.1% | 1.1% | 400.71 | 32.9% | 0.7% |
| 80Δ | 364.59 | 44.9% | 0.9% | 403.94 | 31.8% | 0.5% |
20Δ
- Pseudo strike
- 415.85
- IV
- 53.0%
- B/E move
- 8.6%
- Pseudo strike
- 363.67
- IV
- 47.8%
- B/E move
- 6.7%
25Δ
- Pseudo strike
- 410.98
- IV
- 54.7%
- B/E move
- 7.7%
- Pseudo strike
- 368.12
- IV
- 48.1%
- B/E move
- 5.8%
30Δ
- Pseudo strike
- 403.42
- IV
- 47.8%
- B/E move
- 5.9%
- Pseudo strike
- 372.94
- IV
- 44.2%
- B/E move
- 4.7%
35Δ
- Pseudo strike
- 397.89
- IV
- 44.0%
- B/E move
- 4.7%
- Pseudo strike
- 378.03
- IV
- 37.3%
- B/E move
- 3.5%
40Δ
- Pseudo strike
- 394.29
- IV
- 43.9%
- B/E move
- 4.1%
- Pseudo strike
- 381.56
- IV
- 34.1%
- B/E move
- 2.7%
45Δ
- Pseudo strike
- 390.68
- IV
- 43.7%
- B/E move
- 3.5%
- Pseudo strike
- 384.11
- IV
- 33.3%
- B/E move
- 2.3%
50Δ
- Pseudo strike
- 387.44
- IV
- 42.6%
- B/E move
- 3.0%
- Pseudo strike
- 386.65
- IV
- 32.4%
- B/E move
- 2.0%
55Δ
- Pseudo strike
- 384.28
- IV
- 41.3%
- B/E move
- 2.5%
- Pseudo strike
- 389.20
- IV
- 31.6%
- B/E move
- 1.6%
60Δ
- Pseudo strike
- 381.11
- IV
- 40.0%
- B/E move
- 2.0%
- Pseudo strike
- 391.98
- IV
- 31.7%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 377.55
- IV
- 40.4%
- B/E move
- 1.6%
- Pseudo strike
- 394.86
- IV
- 32.2%
- B/E move
- 1.1%
70Δ
- Pseudo strike
- 373.76
- IV
- 41.8%
- B/E move
- 1.4%
- Pseudo strike
- 397.75
- IV
- 32.7%
- B/E move
- 0.9%
75Δ
- Pseudo strike
- 369.97
- IV
- 43.1%
- B/E move
- 1.1%
- Pseudo strike
- 400.71
- IV
- 32.9%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 364.59
- IV
- 44.9%
- B/E move
- 0.9%
- Pseudo strike
- 403.94
- IV
- 31.8%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 32.64% | |
| 32.18% | |
| 34.65% | |
| 39.99% | |
| 42.18% | |
| 32.02% | |
| 32.52% | |
| 32.38% | |
| 31.98% | |
| 31.56% | |
| 32.19% | |
| 31.96% | |
| 31.84% | |
| 31.99% | |
| 31.64% | |
| 31.83% | |
| 33.70% | |
| 33.50% | |
| 33.57% | |
| 33.21% | |
| 34.40% | |
| 36.81% | |
| 36.00% | |
| 40.43% | |
| 34.49% | |
| 34.50% | |
| 34.58% | |
| 34.80% | |
| 34.65% | |
| 36.09% | |
| 36.85% | |
| 36.79% | |
| 36.45% | |
| 37.57% | |
| 36.98% | |
| 36.26% | |
| 38.25% | |
| 38.48% | |
| 38.95% | |
| 39.27% | |
| 41.57% | |
| 42.74% | |
| 41.63% | |
| 46.61% | |
| 40.87% | |
| 41.29% | |
| 41.58% | |
| 40.72% | |
| 41.35% | |
| 41.39% | |
| 42.34% | |
| 42.14% | |
| 41.29% | |
| 41.54% | |
| 43.45% |
Medical Devices
BRKR
Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and…
More →BSX
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional…
More →BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing clinical treatments that involve and enhance the body's natural healing process in the United…
More →BWAY
Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company…
More →CATX
Description unavailable
More →CBLL
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in…
More →